3714 J. Am. Chem. Soc., Vol. 119, No. 16, 1997
Larksarp and Alper
Anal. Calcd for C12H12ClNO2: C, 60.64; H, 5.09; N, 5.89. Found:
C, 60.32; H, 4.88; N, 6.01.
MS (m/e) 324 [M]+. Anal. Calcd for C19H20N2O3: C, 70.35; H, 6.21;
N, 8.64. Found: C, 70.67; H, 5.99; N, 8.64.
N-Phenyl-3-phenyl-4-vinyl-1,3-oxazolidin-2-imine (5a)4e (R ) H,
N-o-Tolyl-3-o-tolyl-4-vinyl-1,3-oxazolidin-2-imine (5f) (R ) H, X
) o-CH3C6H5N, Y ) o-CH3C6H5N): mp ) 68-69 °C; IR (CdN)
1688 cm-1; 1H NMR (CDCl3) 2.09 (s, 3H), 2.36 (s, 3H), 4.06 (m, 1H),
4.54 (m, 2H), 5.13 (m, 2H), 5.69 (m, 1H), 6.77-7.27 (m, 8H); 13C
NMR (CDCl3) 18.34, 63.16, 69.65, 121.06, 122.29, 122.71, 125.76,
126.66, 127.65, 129.81, 130.54, 131.16, 134.38, 136.49, 137.08, 146.66,
150.34; MS (m/e) 292 [M]+. Anal. Calcd for C20H22N2O: C, 78.40;
H, 7.24; N, 9.14. Found: C, 78.19; H, 6.84; N, 9.54.
X ) C6H4N, Y ) C6H4N): mp ) 58-59 °C; IR (CdN) 1678 cm-1
;
1H NMR (CDCl3) 4.06 (dd, 1H, J ) 5.9 and 8.2 Hz), 4.45 (dd, 1H, J
) 8.3 and 8.3 Hz), 4.72 (m, 1H), 5.40 (m, 2H), 5.85 (m, 1H), 7.10-
7.75 (m, 10H); 13C NMR (CDCl3) 61.07, 70.02, 120.60, 122.60, 123.22,
124.23, 124.63, 129.36, 129.44, 135.69, 139.39, 148.28, 150.65; MS
(m/e) 264 [M]+.
N-(p-Chlorophenyl)-3-(p-chlorophenyl)-4-vinyl-1,3-oxazolidin-2-
imine (5b) (R ) H, X ) p-ClC6H4N, Y ) p-ClC6H4N): mp ) 95-96
N-r-Naphthyl-3-r-naphthyl-4-vinyl-1,3-oxazolidin-2-imine (5g)
(R ) H, X ) 1-naphthyl, Y ) 1-naphthyl): mp ) 172-173 °C; IR
(CdN) 1676 cm-1; 1H NMR (CDCl3) 4.20 (t, 1H), 4.69 (m, 2H), 5.03
(m, 2H), 5.78 (m, 1H), 7.00-8.60 (m, 14H); 13C NMR (CDCl3) 63.84,
70.08, 121.24, 122.21, 123.25, 123.30, 124.39, 124.56,125.40, 125.63,
126.26, 126.48, 127.51, 128.41, 128.64, 129.33, 134.15, 134.27, 134.78,
144.0, 152.06; MS (m/e) 364 [M]+, 365 [M + 1]+. Anal. Calcd for
C25H20N2O: C, 82.39; H, 5.53; N, 7.69. Found: C, 82.03; H, 5.25; N,
7.80.
1
°C; IR (CdN) 1677 cm-1; H NMR (CDCl3) 4.07 (dd, 1H, J ) 6.0
and 8.3 Hz), 4.45 (dd, 1H, J ) 8.3 and 8.3 Hz), 4.75 (m, 1H), 5.35 (m,
2H), 5.81 (m, 1H), 7.00-7.75 (m, 8H); 13C NMR (CDCl3) 61.17, 70.05,
121.22, 123.92, 125.40, 128.19, 129.15, 129.36, 129.92, 134.98, 137.49,
146.28, 150.62; MS (m/e) 332 [M]+, 336 [M + 2]+. Anal. Calcd for
C17H14Cl2N2O: C, 61.28; H, 4.23; N, 8.41. Found: C, 61.43; H, 4.05;
N, 8.38.
N-p-Tolyl-3-p-tolyl-4-methyl-4-vinyl-1,3-oxazolidin-2-imine (5j)
(R ) CH3, X ) p-CH3C6H5N, Y ) p-CH3C6H5N): mp ) 136-137
N-p-Phenyl-3-p-phenyl-4-methyl-4-vinyl-1,3-oxazolidin-2-imine
(5h) (R ) CH3, X ) C6H5N, Y ) C6H5N): mp ) 82-83 °C; IR (CdN)
1
°C; IR (CdN) 1672 cm-1; H NMR (CDCl3) 1.37 (s, 3H), 2.20 (s,
1
1677 cm-1; H NMR (CDCl3) 1.38 (s, 3H), 4.10 (dd 2H, J ) 8.2 and
3H), 2.27 (s, 3H), 4.12 (dd, 2H, J ) 8.2 and 25.1 Hz), 5.17 (m, 2H),
6.00 (m, 1H), 6.80-7.30 (m, 8H); 13C NMR (CDCl3) 20.67, 20.81,
21.05, 64.05, 76.21, 116.86, 123.23, 127.91, 128.94, 129.46, 131.53,
133.77, 136.47, 139.69, 144.59, 152.09; MS (m/e) 306 [M]+. Anal.
Calcd for C20H22N2O: C, 78.40; H, 7.24; N, 9.14. Found: C, 78.13;
H, 7.26; N, 9.12.
25.4 Hz), 5.19 (m, 2H), 6.00 (m, 1H), 6.80-7.40 (m, 10H); 13C NMR
(CDCl3) 20.72, 64.07, 76.24, 116.86, 122.23, 123.43, 126.03, 127.48,
128.37, 128.72, 136.84, 139.64, 147.52, 151.57; MS (m/e) 278 [M]+.
Anal. Calcd for C18H18N2O: C, 77.67; H, 6.52; N, 10.07. Found: C,
77.60; H, 6.25; N, 10.01.
N-(p-Chlorophenyl)-3-(p-chlorophenyl)-4-methyl-4-vinyl-1,3-ox-
azolidin-2-imine (5i) (R ) CH3, X ) p-ClC6H5N, Y ) p-ClC6H5N):
General Procedure for the Asymmetric Palladium-Catalyzed
Cycloaddition Reaction of Vinyloxiranes with Heterocumulenes. A
mixture of Pd2(dba)3‚CHCl3 (0.03 mmol), chiral phosphine ligand (0.06
mmol), and THF was stirred at room temperature for 30 min. Oxirane
(1.0 mmol) and heterocumulene (1.0 mmol) were added, and the mixture
was then stirred under nitrogen atmosphere at either room temperature
or at 10 °C, until the conversion of the heterocumulenes was completed
(as monitored by the shift of the IR-absorption band of the carbodiimide
CdN group at approximately 2100 cm-1 was shifted to the region of
1670 cm-1; the absorption band of the isocyanate unit at about 2200
cm-1 was replaced by one in the region of 1750 cm-1). After the
reaction was complete, the orange brown solution was subjected to
rotary evaporation and the residue was purified by preparative silica
gel TLC. The purified product was rechromatographed on preparative
HPLC to eliminate the rest of the chiral phosphine ligand. The
enantiomeric excess was determined by measuring the area chromato-
gram peaks (obtained from programming an analytical HPLC integra-
tor). Melting points, IR, NMR, MS, and analytical data for 4 and 5
are as follows:
1
mp ) 97-98 °C; IR (CdN) 1675 cm-1; H NMR (CDCl3) 1.39 (s,
3H), 4.14 (dd, 2H, J ) 8.2 and 24.6 Hz), 5.22 (m, 2H), 5.98 (m, 1H),
6.90-7.27 (m, 8H), 13C NMR (CDCl3) 20.50, 64.17, 76.40, 117.5,
124.77, 127.44, 128.39, 128.78, 128.99, 132.02, 135.06, 139.04,
145.70, 151.70; MS (m/e) 346 [M]+, 348 [M + 2]+. Anal. Calcd for
C18H16N2OCl2: C, 62.26; H, 4.64; N, 8.07. Found: C, 62.18; H, 4.40;
N, 7.86.
N-(p-Methoxyphenyl)-3-(p-methoxyphenyl)-4-methyl-4-vinyl-1,3-
oxazolidin-2-imine (5k) (R ) CH3, X ) p-CH3OC6H5N, Y )
1
p-CH3OC6H5N): mp ) 60-61 °C; IR (CdN) 1677 cm-1; H NMR
(CDCl3) 1.34 (s, 3H), 3.68 (s, 3H), 3.72 (s, 3H), 4.12 (dd, 2H, J ) 8.2
and 26 Hz), 5.15 (m, 2H), 5.99 (m, 1H), 6.69-7.23 (m, 8H); 13C NMR
(CDCl3) 20.62, 55.33, 63.85, 75.96, 113.61, 114.07, 116.79, 124.16,
129.23, 129.85, 139.56, 140.77, 152.12, 154.82, 158.21; MS (m/e) 338
[M]+. Anal. Calcd for C20H22N2O3: C, 70.98; H, 6.55; N, 8.28.
Found: C, 70.75; H, 6.35; N, 7.99.
General Procedure for the Determination of the Effect of
Temperature on the Cycloaddition Reaction. A mixture of Pd2-
(dba)3‚CHCl3 (0.03 mmol), (S)-TolBINAP (0.06 mmol), and 3 mL of
THF was stirred at room temperature for 30 min. 2-Vinyloxirane (1a,
1 mmol) and carbodiimide 3a or 3b (1 mmol) were added, the mixture
was then stirred under nitrogen at a given temperature (see Table 5 for
the reaction time and temperature in each case). The reaction was then
concentrated by rotary evaporation, and the crude product was purified
by silica gel TLC using 1:1 n-pentane/ether as the developer. The
results are summarized in Table 4.
N-p-Tolyl-3-p-tolyl-4-vinyl-1,3-oxazolidin-2-imine (5c) (R ) H,
X ) p-CH3C6H5N, Y ) p-CH3C6H5N): mp ) 102-103 °C; IR (CdN)
1679 cm-1; 1H NMR (CDCl3) 2.21 (s, 3H), 2.24 (s, 3H), 3.99 (dd, 1H,
J ) 6.4 and 8.3 Hz), 4.44 (dd, 1H, J ) 8.3 and 8.3 Hz), 4.68 (m, 1H),
5.26 (m, 2H), 5.74 (m, 1H), 6.85-7.42 (m, 8H); 13C NMR (CDCl3)
21.52, 61.57, 69.89, 120.65, 123.08, 123.73, 129.73, 129.93, 132.19,
134.41, 135.79, 136.62, 145.50, 150.81; MS (m/e) 292 [M]+. Anal.
Calcd for C19H20N2O: C, 78.05; H, 6.89; N, 9.58. Found: C, 77.86;
H, 6.84; N, 9.54.
N-(p-Bromophenyl)-3-(p-bromophenyl)-4-vinyl-1,3-oxazolidin-2-
imine (5d) (R ) H, X ) p-BrC6H5N, Y ) p-BrCH3C6H5N): mp )
Single-Crystal X-ray Diffraction Study Of 5b. Crystals of 5b were
obtained by purification using preparative TLC, preparative HPLC, and
recrystallization from methanol. One of the crystals having proximate
dimension of 0.2, 0.2, and 0.2 mm was mounted on a glass capillary.
All the measurements were made on a Siemens CCD diffractometer
with Mo KR radiation. Cell constants and an orientation matrix for
data collection were obtained from least-squares refinement using the
setting angles of 5734 reflections in the range 3° < 2θ < 57° and
corresponded to a monoclinic cell with dimensions a ) 9.7465(4) Å,
b ) 13.0803(6) Å, c ) 12.8570(6) Å, and â ) 103.015(1)°. For Z )
4 and FW ) 333.21, the calculated density is 1.386 g/cm3. On the
basis of the systematic absences, the space group was determined to
be P21. The data were collected at -100 °C using ω-2θ scan
technique to a maximum 2θ value of 57°.
1
98-99 °C; IR (CdN) 1675 cm-1; H NMR (CDCl3) 4.05 (dd, 1H, J
) 6.3 and 8.0 Hz), 4.49 (dd, 1H, J ) 8.0 and 8.0 Hz), 4.71 (m, 1H),
5.31 (m, 2H), 5.74 (m, 1H), 6.83-7.52 (m, 8 H); 13C NMR (CDCl3)
60.40, 69.36, 115.31, 117.03, 120.53, 123.49, 125.12, 131.39, 131.62,
134.29, 137.27, 145.99, 149.77; MS (m/e) 422 [M]+, 424 [M + 2]+.
Anal. Calcd for C17H14N2OBr: C, 48.37; H, 3.34; N, 6.64. Found:
C, 48.38; H, 3.06; N, 6.59.
N-(p-Methoxyphenyl)-3-(p-methoxyphenyl)-4-vinyl-1,3-oxazoli-
din-2-imine (5e) (R ) H, X ) p-CH3OC6H5N, Y ) p-CH3OC6H5N):
1
mp ) 65-66 °C; IR (CdN) 1678 cm-1; H NMR (CDCl3) 3.67 (s,
3H), 3.69 (s, 3H), 3.97 (dd, 1H, J ) 6.6 and 8.0 Hz), 4.42 (dd, 1H, J
) 8.0 and 8.0 Hz), 4.57 (m, 1H), 5.21 (m, 2H), 5.70 (m, 1H), 6.69-
7.39 (m, 8H); 13C NMR (CDCl3) 55.21, 61.31, 69.09, 113.57, 113.84,
120.03, 123.98, 124.58, 131.40, 134.96, 140.51, 150.46, 154.80, 156.37;
A total of 11377 reflections was collected. The unique set contained
7678 reflections. The data were corrected for Lorentz and polarization